Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
IPM receives multi-year award from UK government to advance technologies for women's HIV

The nonprofit International Partnership for Microbicides (IPM) announced today that it has received a £12 million (US$15.6 million) award over four years from the United Kingdom government through the Department for International Development to advance promising HIV and multipurpose prevention products that women could use to protect their sexual and reproductive health.

Published
20 July 2017
From
Eurekalert Medicine & Health
Pre-exposure prophylaxis (PrEP) soon in Ukraine

The clients of the “ALLIANCE.GLOBAL”, PO will be the first in Ukraine to be able to use free pre-exposure prophylaxis of HIV infection (PrEP) already in 2017.

Published
20 July 2017
From
PO Alliance Global
Wales: Trial of 'game-changing' HIV drug gets underway

Trials of a drug to protect people against contracting HIV get underway this week in Wales. The drug, known as PrEP (pre-exposure prophylaxis) can be taken 'on demand' in order to protect against infection.

Published
19 July 2017
From
ITV News
The 2017 Pipeline Report

Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
19 July 2017
From
Treatment Action Group
PrEPARED in Wales

Information on getting PrEP from the NHS in Wales.

Published
18 July 2017
From
Frisky Wales
Labour pledges to fund anti-HIV meds

The Labour Party is accusing the government of dragging its heels on funding a drug which could prevent a large percentage of HIV transmissions.

Published
17 July 2017
From
Radio New Zealand
Drug reducing risk of HIV transmission in healthy people okayed

A drug named Truvada that can reduce the risk of contracting HIV from sexual contact by more than 90%, and by more than 70% for people who inject drugs, has been approved by the Health Ministry for marketing in Israel.

Published
17 July 2017
From
The Jerusalem Post
PrEP conspiracies and stigma are killing us

Two studies have shown that the people who have the highest risk of acquiring HIV are the ones most likely prevented from taking PrEP by beliefs about what using the HIV prevention drug might say about them, or whether they are being used through PrEP. Stigma continues to interfere in our health care and this country’s history of medical racism casts a long shadow.

Published
15 July 2017
From
The Advocate
IPM's dapivirine vaginal ring now under review by European Medicines Agency

The nonprofit International Partnership for Microbicides (IPM) is pleased to announce that its application for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection via vaginal intercourse in HIV-negative women in combination with safer sex practices, has been validated and is now under review by the European Medicines Agency (EMA).

Published
14 July 2017
From
Eurekalert Medicine & Health
An easy-to-read explanation of using antibodies for PrEP

Although the research on antibodies for HIV prevention, treatment and cure can be confusing, it’s an exciting area of inquiry. Here, you’ll find an easy-to-read primer about HIV prevention with antibodies, and what you can be on the look-out for if new HIV prevention options (hopefully) start moving from the laboratory into the real world.

Published
14 July 2017
From
BETA blog
← First12345...116Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.